Qure.Ai Technologies Private
Health tech company using deep learning and artificial intelligence to make healthcare more equitable for patients worldwide.
Last updated September 10, 2026
AI crawler reads
No AI crawler has read this profile since Oct 28, 2026.
Overview
Qure.ai is a health tech company that uses deep learning and artificial intelligence to make healthcare more equitable for patients worldwide. Its solutions, backed by multiple FDA clearances, support the identification and management of diseases including lung cancer, tuberculosis (TB), pediatric TB, and stroke, and advance work across the pharmaceutical and medical device industries. The company reports 45M+ lives impacted to date across 105+ countries via 5500+ sites.
History
Qure.ai's journey began with its inception in 2016. In 2017 it received the Netexplo award for innovative healthcare AI, and in 2018 it was the first AI company to be featured in the Lancet and received CE certification for its Brain CT product. In 2019 it won the TB Quest Awards supported by India Health Fund. In 2020 it raised Series A funding from Sequoia Capital and Mass Mutual Ventures, received the most comprehensive FDA clearance for its Brain CT product, launched an AI solution for COVID-19, and partnered with AstraZeneca for lung cancer screening using a Chest X-ray solution. In 2021 its CEO Prashant Warier received the Forbes Leadership Award for exemplary work during COVID-19, it was featured in CB Insights' most promising health-tech startups, received FDA certification for Brain CT quantification capabilities, and received WHO endorsement for its Chest X-ray solution for TB screening to be used in absence of a human reader. In 2022 it won the Small Business Research Initiative Healthcare Funding. In 2023 it was a Deloitte Technology Fast 50 India 2023 Category Winner, won First Prize at the AI Gamechanger Awards, and received the Biospectrum Excellence AI Awards: Emerging BioStartup of the Year. In 2024 it received the Siemens Healthineers Startup Award. In 2025 it was recognized among TIME's 100 Most Influential Companies.
Recent events
Qure.ai appoints Mihir Bhanushali as Executive Vice President, Global Health[4]
Reported:
Qure.ai announced the appointment of Mihir Bhanushali as Executive Vice President, Global Health, to lead its growth across low- and middle-income countries, focusing on Africa, Southeast Asia, South Asia and Latin America.
Fujifilm and Qure.ai partner on AI-assisted X-ray solutions[5]
Reported:
Fujifilm India announced that FUJIFILM Corporation had introduced X-ray solutions augmented with Qure.ai's qXR software, which analyzes X-ray images to flag abnormal findings. The companies described the partnership as supporting care providers and expanding tuberculosis screening in India and other developing countries.
Sources5 sources
Cite this profile: Cite the canonical profile. /brand-wiki/qureai-technologies-private · Editorial policy · How profiles are compiled